Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
BMS pays $65M to expand Repertoire of autoimmune assets
The deal, which features up to $1.8 billion in future payments, covers tolerizing vaccines for up to three autoimmune diseases.
Nick Paul Taylor
Apr 29, 2024 6:15am
BMS closes Redwood City cell therapy research site
Apr 26, 2024 10:59am
Sponsored
Patient Access and Affordability: PhRMA shares how we can put patients first
Feb 12, 2024 8:00am
Gilead gives up on $4.9B antibody magrolimab
Apr 26, 2024 10:04am
Sponsored
Cognizant & Takeda Discuss Digital Transformation in Lifescience
Feb 12, 2024 8:00am
Xaira, Anthos, CureVac & more—Chutes & Ladders
Apr 26, 2024 8:30am